BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2409027)

  • 1. Mediator release after allergic and physical nasal challenges.
    Norman PS; Naclerio RM; Creticos PS; Togias A; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):57-63. PubMed ID: 2409027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
    Creticos PS; Adkinson NF; Kagey-Sobotka A; Proud D; Meier HL; Naclerio RM; Lichtenstein LM; Norman PS
    J Clin Invest; 1985 Dec; 76(6):2247-53. PubMed ID: 2416777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
    Pipkorn U; Proud D; Lichtenstein LM; Schleimer RP; Peters SP; Adkinson NF; Kagey-Sobotka A; Norman PS; Naclerio RM
    J Clin Invest; 1987 Oct; 80(4):957-61. PubMed ID: 2443539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement.
    Togias AG; Naclerio RM; Proud D; Fish JE; Adkinson NF; Kagey-Sobotka A; Norman PS; Lichtenstein LM
    J Clin Invest; 1985 Oct; 76(4):1375-81. PubMed ID: 2414318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediator release after nasal airway challenge with allergen.
    Naclerio RM; Meier HL; Kagey-Sobotka A; Adkinson NF; Meyers DA; Norman PS; Lichtenstein LM
    Am Rev Respir Dis; 1983 Oct; 128(4):597-602. PubMed ID: 6354022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains.
    Lebel B; Bousquet J; Morel A; Chanal I; Godard P; Michel FB
    J Allergy Clin Immunol; 1988 Nov; 82(5 Pt 1):869-77. PubMed ID: 2461405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen.
    Proud D; Sweet J; Stein P; Settipane RA; Kagey-Sobotka A; Friedlaender MH; Lichtenstein LM
    J Allergy Clin Immunol; 1990 May; 85(5):896-905. PubMed ID: 1692049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mediators in late antigen-induced rhinitis.
    Naclerio RM; Proud D; Togias AG; Adkinson NF; Meyers DA; Kagey-Sobotka A; Plaut M; Norman PS; Lichtenstein LM
    N Engl J Med; 1985 Jul; 313(2):65-70. PubMed ID: 2582257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arachidonic acid metabolites during nasal challenge.
    Brown MS; Peters SP; Adkinson NF; Proud D; Kagey-Sobotka A; Norman PS; Lichtenstein LM; Naclerio RM
    Arch Otolaryngol Head Neck Surg; 1987 Feb; 113(2):179-83. PubMed ID: 3099812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of azelastine on the early allergic response.
    Shin MH; Baroody F; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    Clin Exp Allergy; 1992 Feb; 22(2):289-95. PubMed ID: 1349259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy.
    Hedlin G; Silber G; Schieken L; Naclerio R; Proud D; Eggleston P; Adkinson NF
    J Allergy Clin Immunol; 1989 Sep; 84(3):390-9. PubMed ID: 2476472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of terfenadine on unilateral nasal challenge with allergen.
    Wagenmann M; Baroody FM; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    J Allergy Clin Immunol; 1994 Mar; 93(3):594-605. PubMed ID: 7512101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind study of the discontinuation of ragweed immunotherapy.
    Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
    J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediator release is altered in immunotherapy-treated patients: a 4-year study.
    Dokic D; Nethe A; Kleine-Tebbe J; Kunkel G; Baumgarten CR
    Allergy; 1996 Nov; 51(11):796-803. PubMed ID: 8947337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal inflammatory mediator release in ragweed allergic rhinitis: correlation with cellular influx into nasal secretions.
    Georgitis JW; Stone BD; Gottschlich G
    Int Arch Allergy Appl Immunol; 1991; 96(3):231-7. PubMed ID: 1666629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between histamine and physiological changes during the early response to nasal antigen provocation.
    Baroody FM; Ford S; Proud D; Kagey-Sobotka A; Lichtenstein L; Naclerio RM
    J Appl Physiol (1985); 1999 Feb; 86(2):659-68. PubMed ID: 9931205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinins as mediators of human allergic reactions.
    Proud D; Naclerio RM; Togias AG; Kagey-Sobotka A; Adkinson NF; Norman PA; Lichtenstein LM
    Adv Exp Med Biol; 1986; 198 Pt B():181-7. PubMed ID: 3812100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihistamines on inflammatory mediators.
    Naclerio RM
    Ann Allergy; 1993 Sep; 71(3):292-5. PubMed ID: 7690526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions.
    Raphael GD; Igarashi Y; White MV; Kaliner MA
    J Allergy Clin Immunol; 1991 Jul; 88(1):33-42. PubMed ID: 1712803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal challenge studies with bradykinin: influence upon mediator generation.
    Brunnée T; Nigam S; Kunkel G; Baumgarten CR
    Clin Exp Allergy; 1991 Jul; 21(4):425-31. PubMed ID: 1913265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.